Solving the COVID-19 Vaccine Distribution Challenge
A podcast series where we uncover the supply chain challenges present in the distribution of the Covid-19 vaccine.
Distribution of the vaccine by leveraging the existing cold chain network capacity is set to pose unprecedented challenges in the quest to making the vaccine available to every person in every country.

Latest episodes
The hardest problem in supply chain, ever.
The world must undertake the most logistically difficult vaccination campaign in history, with a hesitant and weary public, and at least one vaccine with unprecedented storage requirements.
The cause for optimism is real – but so are the logistical challenges that lie ahead.
Who are we talking to?

They contribute to the discussion by:
- show-casing the strategy of distribution
- talking about the bottlenecks and challenges they face
- the opportunities that come with solving these problems
- the lessons learnt here that are transferrable to other industries
They contribute to the discussion by:
- discussing the challenges faced in production
- about how the covid-19 vaccine stands out from others
- the human stories and the lives they are touching by producing these vaccines
They contribute to the discussion by:
- discussing their plan of action to rollout the vaccine
- talking about the problems they have been facing
- how this vaccine drive relates to the other vaccine drives of the past
- the tech that is enabling them to disseminate the vaccine
They contribute to the discussion by:
- providing an expert lens to talk about these vaccines
- talking about their research and insights they have on the whole process
- the lessons learnt from previous pandemics
They contribute to the discussion by:
- providing an authoritative take on the decisions made
- a bird's eye view of the whole ditribution process
- the challenges they are facing and how they are being tackled
Why does The Vaccine Challenge exist?
There is significant knowledge-gap when it comes to the supply chain and distribution initiatives within respect to the COVID-19 vaccine, because much of the work is happening behind closed doors.
We want to help catalyse the process by making all possible information available to others working towards a collective goal as well as those that are interested to understand the difficulties associated with this Herculean task.
